Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2024. The report specifically details a transaction in the company's own shares executed on September 12, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
| Metric | Value |
|---|---|
| Date of Purchase | September 12, 2024 |
| Number of Shares Purchased | 725,500 |
| Highest Price Paid per Share | 396.30 pence |
| Lowest Price Paid per Share | 387.30 pence |
| Volume Weighted Average Price | 390.44 pence |
| Registered Share Capital Post-Settlement | 9,119,639,272 ordinary shares |
Material Changes
The primary material change reported is the reduction of the company's registered share capital following the cancellation of 725,500 ordinary shares. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies. It serves as a regulatory disclosure of a specific capital transaction in compliance with the Market Abuse Regulation (Article 5s(1)(b)).
Key Facts for Investor Verification
- Verify the total number of shares repurchased under the August 2024 Buyback Programme to date.
- Confirm the current market price of Haleon shares relative to the 390.44 pence average purchase price.
- Review the full trade breakdown available via the London Stock Exchange link provided in the filing for granular transaction details.
- Check subsequent filings for updates on the remaining authorized buyback capacity.